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Male  and female  CFLP  mice  were  investigated  in  a Crawley  social  interaction  test.
CRF  and UCN  1 decreased  the preference  for  social  novelty  of  male  mice.
CRF1 receptor  mediates  the effects  of  CRF  and  UCN  1 on  male-female  interaction.
UCN  2 and  UCN  3  did  not  influence  the  preference  for  social  novelty  of male  mice.
CRF2 receptor  does  not  participate  to male-female  interaction.
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a  b  s  t  r  a  c  t
The  aim  of the  present  study  was  to  determine  the  role  of  corticotropin-releasing  factor  (CRF),  the  uro-
cortins  (UCN  1, UCN  2 and  UCN  3)  and their  receptors  (CRF1 and  CRF2)  in  the  preference  for  social  novelty
of  mice.  Male  CFLP  mice  were administered  intracerebroventricularly  (ICV)  with  CRF,  UCN  1,  UCN 2
or  UCN  3 and/or  antalarmin  or astressin  2B, selective  antagonists  of  CRF1 receptor  and  CRF2 receptor,
respectively.  The  mice  were  investigated  in  a  Crawley  social  interaction  test  arena  consisting  of  three
chambers:  an  unknown  female  was  set  in  the  first chamber  and  a known  female,  with  which  the  male
was  familiarized  previously  for 24  h, was set  in the  third  chamber.  First  the  tested  male  was  habituated
with  the  middle  chamber  for 5  min  and  then  allowed  to  explore  the  remaining  chambers  for  5 min,  during
which  the number  of  entries  and  the  time  of  interaction  were  measured.  CRF  decreased  significantly  the
number  of entries  and the  time  of  interaction  with  the  unknown  female,  but  not  the  known  female.  UCN
1 decreased  significantly  the number  of  entries  into  the  chamber  of the unknown  female,  but  not  the
known  female,  without  changing  the  time  of interaction.  All  decreasing  effects  were  reversed  by anta-
larmin, but  not  astressin  2B.  UCN  2 and UCN  3 didn’t  influence  significantly  any  of  the  parameters.  The
present  study  suggests  that  CRF  and  UCN 1 decrease  the  preference  for social  novelty  by activating  CRF1
receptor,  while  UCN  2 and  UCN  3, activating  selectively  CRF2 receptor,  do not  participate  to  male-female
interaction.
©  2017  Elsevier  B.V.  All  rights  reserved.. Introduction
Corticotropin-releasing factor (CRF) is a hypothalamic neuro-
ormone and also an extrahypothalamic neurotransmitter that
egulates the endocrine, autonomic and behavioral responses to
tress [1]. During stress CRF, along with the synergistic arginine-
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166-4328/© 2017 Elsevier B.V. All rights reserved.vasopressin (AVP), is released from the paraventricular nucleus of
the hypothalamus (PVN) and, getting into the circulation through
the median eminence, stimulates the release of the adrenocorti-
cotropic hormone (ACTH) in the anterior pituitary [1]. ACTH, in turn
stimulates the synthesis of glucocorticoids in the adrenal cortex
resulting in elevation of the concentration of the plasma glucocorti-
coids [2]. The elevation of the plasma glucocorticoid concentration
not only reflects the activation of the hypothalamic-pituitary-
adrenal (HPA) axis, but also exerts negative feedback effect on
the hypothalamic CRF and the pituitary ACTH release, inhibiting
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CTH secretion in the anterior pituitary that peaks in 15 min  and
ay  decrease the active social interaction. ACTH, in turn stimulates
he synthesis of glucocorticoids in the adrenal cortex resulting in
levation of the concentration of the plasma glucocorticoids [2].
he elevation of the plasma glucocorticoid concentration not only
eflects the activation of the hypothalamic-pituitary-adrenal (HPA)
xis, but also exerts negative feedback effect on the hypothalamic
RF and the pituitary ACTH release, inhibiting the HPA axis.
Since CRF was firstly isolated [1], a growing family of CRF-like
eptides have been discovered. Today the mammalian members
f this family include four ligands: CRF, urocortin 1 (UCN 1) [4],
rocortin 2 (UCN 2), also known as stresscopin-related peptide
SRP) [5], and urocortin 3 (UCN 3), also known as stresscopin (SCP)
6], two receptors (CRF1 and CRF2) [7] and one binding protein
CRF-BP) [8]. The name urocortin derives from the fish homologue
rotensin (63% sequence identity) and the mammalian analogue
orticotropin (45% sequence identity) [9], as the urocortins share
ommon amino acidic elements (45–33%), but have different phar-
acological properties compared to CRF. CRF binds preferentially
o CRF1 receptor, while UCN 1 attaches equipotently to both CRF
eceptors (CRF1 and CRF2), and UCN 2 and UCN 3 bind selectively
o CRF2 receptor [10]. These receptors belong to the class B subtype
f G protein-coupled receptors (GPCRs) and, like all GPCRs, con-
ist of an amino-terminal extracellular region, a carboxyl-terminal
ntracellular tail and seven, transmembrane segments, connected
y alternating intracellular and extracellular loops [11]. There is
early 70% identity between CRF1 and CRF2 receptors at the amino
cid level with the transmembrane and intracellular domains of the
RF receptors presenting the highest homology (over 80% identity)
11]. In addition, CRF and UCN 1 can be found attached to CRF-BP
10], which was found in the brain and the pituitary and is thought
o inhibit the actions of CRF and UCN 1 [8].
As regards the anatomical distribution of the ligands, they are
epresented both in the brain and the peripheral tissues [12].
RF is synthesized mainly in the hypothalamus (PVN), the central
ucleus of the amygdala and the hindbrain regions in the CNS, and
xpressed in the gut, skin, and adrenal gland in the periphery. UCN
 expression has been described predominantly in the Edinger-
estphal nucleus in the brain and expressed in the gastrointestinal
ract, testis, cardiac myocytes, thymus, skin, and spleen in the
eriphery. UCN 2 expression has been detected in the hypotha-
amus (e.g. arcuate nucleus), the brainstem and the spinal cord in
he central nervous system (CNS), and in the heart, the blood cells
nd the adrenal gland in the periphery. UCN 3 expression has been
bserved in the amygdala (e.g. medial nucleus) in the CNS, and in
he gastrointestinal tract and the pancreas in the periphery [13].
As regards the anatomical localization of the receptors, CRF1
eceptor is represented more anundantly in the CNS, whereas CRF2
eceptor is distributed predominantly in the periphery [12]. In the
NS, CRF1 receptor is expressed in the cerebral cortex, the cerebel-
um and the anterior pituitary, but also found in the amygdala, the
triatum and the hypothalamus [14]. CRF2 receptor is limited cen-
rally to subcortical regions: the amygdala, the hippocampus and
he hypothalamus and scattered all over the periphery: the heart,
he gastro-intestinal tract, the lung, the skeletal muscles and the
essels [14].
Besides their principal role in the modulation of stress responses
15–18], regulation of food intake and satiety [19], gastrointesti-
al motility [20], vasodilation and cardioprotection [21], CRF and
he CRF-related peptides have been implicated in social interaction
22–24], although their intimate role was not investigated thor-
ughly [25,26]. Hence, the aim of our study was  to determine the
ole of CRF, the urocortins (UCN 1, UCN 2 and UCN 3) and their
eceptors (CRF1 and CRF2) in the preference for social novelty of
ice.esearch 324 (2017) 146–154 147
2. Materials and methods
2.1. Animals
Male and female CFLP mice weighing 24–30 g were used. The
total number of mice was  504, of which 168 males and 336 females
(divided in 168 partner females and 168 stranger females). CFLP
mice were used because we  intended to test an outbred strain of
mice, rather than an inbred strain, such as C57/BL6 mice, which,
according to previous studies, fail to exhibit preference for social
novelty in the three-chamber apparatus [27]. Female mice were
used as partners or strangers instead of the male mice, because we
aimed to investigate the preference for social novelty following pair
bond formation (male-female interaction), and not social affiliation
(male–male interaction). Four-five males were housed together in
their home cages and separated from the stranger females, but then
kept together with the partner females for 24 h before the experi-
ments started. During the experiments the animals were kept and
handled in accordance with the instructions of the University of
Szeged Ethical Comittee for the Protection of Animals in Research,
at constant room temperature (23 ◦C) on a standard illumination
schedule, with 12-h light and 12-h dark periods (lights on from 6:00
a.m.). Commercial food and tap water were available ad libitum. All
experiments were performed in accordance with the ARRIVE guide-
lines and the U.K. Animals (Scientific Procedures) Act, 1986 and
associated guidelines, EU Directive 2010/63/EU for animal experi-
ments.
2.2. Surgery
The mice were implanted with a stainless steel Luer can-
nula of 10 mm  length and 0.4 mm  diameter aimed at the right
lateral cerebral ventricle under anesthesia with 60 mg/kg Euthana-
sol (CEVA-Phylaxia, Hungary). The stereotaxic coordinates were
0.5 mm posterior and 0.5 mm lateral to the bregma, and 3 mm deep
from the dural surface, adapted from the atlas describing the mouse
brain in stereotaxic coordinates [28]. Cannulas were secured to the
skull with dental cement and acrylate. The polyethylene tube of the
injector having 0.8 mm outside diameter and 0.4 mm inside diam-
eter was  fitted closely into the cannula with a sharp pointing tip
projecting beyond the cannula. The mice were allowed for 5 days
to recover after the surgery and the permeability of the canulla was
tested with methylene-blue after the experiments. The hit and miss
ratio was  168–143, which means 85% for right positioning of the
cannula.
2.3. Treatment
Four experiments were performed with four different groups. In
experiment I, the first group was treated with 2 l saline solution,
the second one with 5 g/2 l CRF, the third one with 0.1 g/2 l
of the selective CRF1 receptor antagonist antalarmin and the
fourth one with 1 g/2 l of the selective CRF2 receptor antagonist
astressin 2B, 30 min  before the social interaction test. In experi-
ment II, the first group was treated with 2 l saline, the remaining
groups were treated with 5 g/2 l CRF, 30 min  before the test
and pretreated in order with 2 l saline, 0.1 g/2 l antalarmin
or 1 g/2 l astressin 2B, 60 min  before the test. In experiment III,
the first group was treated with 2 l saline, the second, the third
and the fourth ones with 5 g/2 l UCN 1, 5 g/2 l UCN 2 and
5 g/2 l UCN 3, respectively, 30 min  before the test. In experiment
IV, the first group was treated with 2 l saline, the remaining groups
were treated with 5 g/2 l UCN 1, 30 min  before the test and pre-
treated in order with 2 l saline, 0.1 g/2 l antalarmin or 1 g/2 l
astressin 2 B 60 min  before the test. The saline (0.9% NaCl) solution
was provided by Biogal Ltd., Hungary, CRF, UCN 1, UCN 2 and UCN

























































The effects of CRF, antalarmin and astressin 2B on the preference for social novelty
of  mice.
Number of entries
ANOVA table SS DF MS F (DFn, DFd) p value
Interaction 92.05 6 15.34 F (6,108): 3.582 p = 0.0028
Novelty 182.2 2 91.08 F (2,108): 21.27 p < 0.0001
Treatment 175.4 3 58.48 F (3,108): 13.65 p < 0.0001
Residual 462.5 108 4.282
Time of interaction
ANOVA table SS DF MS F (DFn, DFd) p value
Interaction 61947 6 10325 F (6, 108): 2.711 p = 0.0172
Novelty 189754 2 94877 F (2, 108): 24.91 p < 0.0001
Treatment 134586 3 44862 F (3, 108): 11.78 p < 0.0001
Residual 411337 108 3809
Abbreviations: SSsum of squares; DFtotal degrees of freedom; MSmean square; F
(DFnDFd)F distribution (degrees of freedom numerator degrees of freedom denom-
inator); P valueprobability value.
Summary of the statistical data from the social interaction test (two-way ANOVA
with factor A = novelty and factor B = treatment was performed).
Table 2
The effects of CRF, CRF with antalarmin and CRF with astressin 2 B on the preference
for social novelty of mice.
Number of entries
ANOVA table SS DF MS F (DFn, DFd) p value
Interaction 58.89 6 9.816 F (6, 84) = 3.905 p = 0.0017
Novelty 50.29 2 25.14 F (2, 84): 10 p = 0.0001
Treatment 98.72 3 32.91 F (3, 84): 13.09 p < 0.0001
Residual 211.1 84 2.513
Time of interaction
ANOVA table SS DF MS F (DFn, DFd) p value
Interaction 43738 6 7290 F (6, 84) = 1.915 p = 0.0877
Novelty 117742 2 58871 F (2, 84): 15.47 p < 0.0001
Treatment 123125 3 41402 F (3, 84): 10.78 p < 0.0001
Residual 319728 84 3806
Abbreviations: SSsum of squares; DFtotal degrees of freedom; MSmean square; F
(DFnDFd)F distribution (degrees of freedom numerator degrees of freedom denom-
inator); P valueprobability value.
Summary of the statistical data from the social interaction test (two-way ANOVA
with factor A = novelty and factor B = treatment was performed).
Table 3
The effects of UCN 1, UCN 2 and UCN 3 on the preference for social novelty of mice.
Number of entries
ANOVA table SS DF MS F (DFn, DFd) p value
Interaction 18.2 6 3.034 F (6, 105): 0.789 p = 0.5801
Novelty 235.9 2 118 F (2, 105): 30.7 p < 0.0001
Treatment 129.8 3 43.28 F (3, 105): 11.26 p < 0.0001
Residual 403.4 105 3.842
Time of interaction
ANOVA table SS DF MS F (DFn, DFd) p value
Interaction 2509 6 418.2 F(6, 105): 0.1446 p = 0.9897
Novelty 268522 2 134261 F (2, 105): 46.43 p < 0.0001
Treatment 4298 3 1433 F (3, 105): 0.495 p < 0.6862
Residual 303621 105 2892
Abbreviations: SSsum of squares; DFtotal degrees of freedom; MSmean square; F48 Z. Bagosi et al. / Behavioural B
 were purchased from Bachem Ltd., Switzerland, and antalarmin
nd astressin 2 B were purchased from Sigma Aldrich Inc., USA. The
CV infusion of the substances was performed with a hand-held
icroinjector (Hormuth Ltd., Germany) and the mice, being previ-
usly handled daily to minimize the effects of nonspecific stress,
ere also hand-held during infusion.
.4. Social interaction test
Thirty minutes after the ICV injection of the peptides mice were
nvestigated in a social interaction test arena described originally by
rawley and colleagues and used to test the sociability and the pref-
rence for social novelty of mice. [29]. In the present experiments
e used a modified version of this test that was meant to investi-
ate the preference for social novelty following pair bond formation
male-female interaction), but not social affiliation (male–male
nteraction). The principle of the test is based on the assessment
hat a wild type mouse would visit and spend more time with the
tranger female over the partner female, indicative for an intact
ocial memory and a natural preference for social novelty.
The apparatus is a rectangular, three-chamber box made from
lear Plexiglass. Each chamber is of 19 × 45 × 25 cm,  with an open
iddle section, which allows free access to each chamber. The right
nd left chambers could be isolated from the middle one by using
wo dividing Plexiglass walls. Two identical, wire cup-like cells of
0 × 17 cm with removable lids that large enough to hold a sin-
le mouse were placed vertically inside the apparatus, one in each
ide chamber. Each cell is comprised of metal wires to allow for
ir exchange between the interior and exterior of the cylinder but
mall enough to prevent direct physical interactions between an
nimal on the inside with one on the outside.
In the present experiments an unknown female mouse (stranger
emale) was set in the first chamber and a known female mouse
partner female), with which the male was familiarized previ-
usly for 24 h, was set in the third chamber. First the tested male
ouse was habituated with the middle chamber for 5 min  and then
llowed to explore the remaining chambers for 5 min, during which
he number of entries and the time of interaction were measured.
he tested male mouse was habituated for the middle compart-
ent for 5 min, but not the other compartments. The partner and
he stranger female mice were transferred in their home cages into
he behavioral room 30 min  before the first trial, but they were not
abituated previously to the compartments. The partner and the
tranger mice were systematically alternated between the left or
ight compartment across the trials to prevent side preference. All
rials were performed between 9:00 a.m. and 13:00 p.m. General
oom lighting was 650 lx. The person who made the observation
as at least 2 m away from the apparatus. After each trial, all cham-
ers were cleaned with 70% ethanol and then with Clidox 1:5:1 to
revent olfactory cue bias and to ensure proper disinfection [30].
.5. Statistical analysis
Statistical analysis of the results was performed by analysis
f variance (ANOVA, GraphPad Prism Software). The differences
etween groups were tested by two-way ANOVA, followed by
ukey post-hoc comparison test. A probability level of 0.05 or
ess was accepted as indicating a statistically significant difference
Tables 1–4 ).
. ResultsCRF decreased significantly the number of entries
F(3,28) = 5.489; p < 0.001) and the time spent in interaction
F(3,28) = 4.641; p < 0.001) with the stranger female, but not
hat with the partner female (F(3,28) = 0.03286; p = 0.9918 and
(DFnDFd)F distribution (degrees of freedom numerator degrees of freedom denom-
inator); P valueprobability value.
Summary of the statistical data from the social interaction test (two-way ANOVA
with factor A = novelty and factor B = treatment was performed).











































control (10) CRF (10) antalarmin (10) astressin 2B (10)
*
*
Fig. 1. The effects of CRF, antalarmin and astressin 2 B on the preference for social novelty of mice. The number of animals used in each group has been indicated in brackets.
Values  are presented as means ± SEM; statistically significant difference was  accepted for p < 0.05 and indicated with * for CRF or antalarmin vs. control.
Table 4
The effects of UCN 1, UCN 1 with antalarmin and UCN 1 with astressin 2B on the
preference for social novelty of mice.
Number of entries
ANOVA table SS DF MS  F (DFn, DFd) p value
Interaction 22.99 6 3.832 F(6, 84): 1.965 p = 0.0799
Novelty 157.1 2 78.54 F (2, 84): 40.26 p < 0.0001
Treatment 156.5 3 52.17 F (3, 84): 26.74 p < 0.0001
Residual 163.9 84 1.951
Table 4 (Continued)
Time of interaction
ANOVA table SS DF MS  F (DFn, DFd) p value
Interaction 35465 6 5911 F(6, 84): 2.187 p: 0.0521
Novelty 322153 2 161077 F (2, 84): 59.59 p < 0.0001
Treatment 25498 3 8499 F (3, 84): 3.144 p = 0.0294
Residual 227046 84 2703
Abbreviations: SSsum of squares; DFtotal degrees of freedom; MSmean square; F
(DFnDFd)F distribution (degrees of freedom numerator degrees of freedom denom-
inator); P valueprobability value.
Summary of the statistical data from the social interaction test (two-way ANOVA
with factor A = novelty and factor B = treatment was performed).


















































Fig. 2. The effects of CRF, CRF with antalarmin and CRF with astressin 2 B on the preference for social novelty of mice. The number of animals used in each group has been











ith  antalarmin vs. CRF.
(3,28) = 0.4039, p = 0.7513), compared to the controls (Fig. 1). In
ddition, the total number of entries (F(3.28) = 16.04; p < 0.001) and
he total time of interaction (F(3.28) = 8.259; p < 0.05) decreased
ignificantly (Fig. 1). Antalarmin and astressin 2 B administered
lone were ineffective (p < 0.05) (Fig. 1). The decreasing effects of
RF were blocked by antalarmin (p < 0.05), but not astressin 2 B
p < 0.05) (Fig. 2).
UCN 1 decreased significantly the number of entries into the
hamber of the unknown female (F(3,35) = 6.277; p < 0.001), but
ot into that with the partner female (F(3,35) = 1.614; p = 0.2036),without changing the times of interaction spent with the part-
ner female (F(3,35) = 0.144; p = 0.09328) or the stranger female
(F(3,35) = 0.2763; p = 0.8421), compared to the control (Fig. 3).
The total number of entries (F(3,35) = 4.827; p < 0.001) decreased
significantly, in contrast with the total time of interaction
(F(3,35) = 0.5033; p = 0.6825) that was  not influenced considerably
by UCN 1 (Fig. 3). UCN 2 and UCN 3 did not influence remarkably
any of the parameters measured (p > 0.05) (Fig. 3). The decreasing
effects of UCN 1 were reversed by antalarmin (p < 0.05), but not
astressin 2 B (p > 0.05) (Fig. 4).











































control (10) urocortin 1 (10) urocortin 2 (10) urocortin 3 (9)
Fig. 3. The effects of UCN 1, UCN 2 and UCN 3 on the preference for social novelty of mice. The number of animals used in each group has been indicated in brackets. Values











re  presented as means ± SEM; statistically significant difference was accepted for 
. Discussion
Previous studies on the possible role of CRF and CRF-related pep-
ides in social behavior of different species have been reviewed in
wo recent studies [25,26]. Despite that the primary focus in these
tudies has been on the effects of social stressors, such as social
efeat and social isolation on the CRF system [26], there have been
lso insights on the role of CRF system in prosocial and affiliative
ehaviors, such as parental care, maternal defense, sexual behav-
or and pair bonding [25]. The aim of the present study was  to
nvestigate the effects of these peptides on the preference for social
ovelty following pair bond formation in mice.5 and indicated with * for UCN vs. control.
Our results demonstrate that central administration of CRF and
UCN 1 induces a decrease of the preference for social novelty via
CRF1 receptor, which may  reflect the anxiogenic action of the CRF1
receptor agonists [31,32]. But CRF1 receptor agonists may  exert
their anxiogenic action through both central and peripheral effects
[31,32]. The central effect can be mediated by different extrahy-
pothalamic brain regions and neuron populations involved in stress
reaction, such as the basolateral nucleus of the amygdala (BLA)
[33]. Previous studies referred that injection of CRF and UCN 1 into
the BLA reduced the times of social interaction in male Wistar rats
and that this effect was completely abolished by administration of
selective CRF1 and non-selective CRF receptor antagonists [34–36].













































control (10) urocortin 1 (10) urocortin 1 + antalarmin (6) urocortin 1 + astressin 2B (6)


















een  indicated in brackets. Values are presented as means ± SEM; statistically signi
 for UCN 1 with antalarmin vs. UCN 1.
CN 1 proved even more potent than CRF in reducing the time of
nteraction, which is consistent with its higher affinity for the CRF1
eceptor [34–36]. The peripheral effect of the CRF1 agonists can
e mediated by activation of the HPA axis. Actually, ICV injection
f the same dose (5 g/2 l) of CRF or UCN I that was  used in the
resent experiments led to elevation of plasma ACTH and corticos-
erone concentrations within 30 min  in our previous experiments
15]. Therefore the impact of the HPA axis activation on the behav-
or of the mice observed in the three-chamber social interaction
est cannot be excluded. In addition, a previous study using ICV
njection of CRF in male Lister rats, suggested that the anxiogenic
ffect of CRF observed in a classical social interaction test [31], can
e caused by the release of pituitary ACTH, since this hormone also
ecreased social interaction without reducing locomotor activity
31,32], but is unlikely to be due by the release of adrenal corticos- difference was accepted for p < 0.05 and indicated with * for UCN 1 vs. control and
terone, since this hormone did not decrease social interaction, and
in some doses increased it [31,32].
Our results also demonstrate that central administration of
UCN 2 and UCN 3 does not alter the preference for social nov-
elty, and generally the social interaction of male mice with female
mice. However, previous studies claimed that male, but not female,
UCN 2 knock-out mice exhibited more passive social interactions
and reduced aggressiveness to novel conspecifics [22] and that
both male and female UCN 3 and CRF2 receptor knock-out mice
expressed an enhanced social memory and increased preference
for social novelty, when compared to wild-type mice [23]. These
studies suggest that CRF2 agonists would modulate some aspects
of social behavior. In contrast, a more recent study stated that mice
deficient in UCN 3 or CRF2 receptor localized specifically in the
medial nucleus of the amygdala (MEA) showed decreased prefer-









































































Z. Bagosi et al. / Behavioural B
f the CRF2 receptors or optogenetic activation of UCN 3 neurons
n the MEA  proved the opposite, an increased preference for social
ovelty of mice. This study suggests that UCN 3 from the MEA  would
odulate the ability of mice to cope with social challenges via CRF2
eceptors [37].
Our experiments were originally inspired by three studies using
our different vole species (prairie, pine, montane and meadow
oles), which, based on their close relationship, but remarkably
ifferent social behavior (prairie and pine voles are monogamous,
hile montane and meadow voles are promiscuous), are consid-
red emerging model organisms for understanding the social brain
38]. In the first study using receptor autoradiography, a marked
ifference in the brain distribution of CRF1 and CRF2 receptors
etween monogamous and promiscuous species (e.g., a higher
xpression of CRF2 receptor and a lower expression of CRF1 recep-
or in the nucleus accumbens (NACC) of the prairie and pine voles),
nd male and female sex (e.g., higher levels of CRF2 receptor bind-
ng in the encapsulated bed nucleus of stria terminalis (BNST) in
ale voles) was demonstrated. In the second study using in situ
ybridization and immunocytochemistry, no difference between
he brain distribution of CRF (the NACC, the BNST, the central
ucleus of the amygdala etc.) and UCN 1 (the Edinger-Westphal
ucleus) was demonstrated between monogamous and promiscu-
us voles [39]. In the third study, microinjection of CRF and UCN 1
nto the NACC induced an acceleration of the partner preference for-
ation in monogamous prairie voles, but not in non-monogamous
eadow voles, that was effectively blocked by intraaccumbal injec-
ion of both selective CRF1 and selective CRF2 receptor antagonists
40]. Taking into consideration that urocortinergic fibers were not
resent in the NACC, this study suggests that the release of CRF in
he NACC facilitates partner preference in the monogamous species
ctivating both CRF receptors [40]. The lack of this facilitation effect
n the non-monogamous species can be explained by the lack of
he correspondent receptors in their brain, despite of the similar
istribution of their ligands [39,41].
In conclusion, the present study suggests that CRF and UCN 1
ecrease the preference for social novelty by activating CRF1 recep-
ors, while UCN 2 and UCN 3, activating selectively CRF2 receptors,
o not participate to male-female interaction in the promiscuous
FLP mice. This conclusion can be underlined by the higher expres-
ion of CRF1 receptors and lower expression of CRF2 receptors in
he brains of non-monogamous species which have been previously
emonstrated.
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